Transcription of WHO Drug Information
{{id}} {{{paragraph}}}
Example: stock market
WHO Drug Information
573 WHO Drug Information Vol. 31, No. 4, 2017 ContentsSafety of medicines575 Priming resource-limited countries for pharmacovigilanceNaming of medicines581 Survey about International Nonproprietary Names (INN)Safety news586 Safety warningsMiconazole oral gel ; Obeticholic acid ; Linagliptine ; Dabigatran ; Flucloxacillin ; Epoetins ; Intraocular vancomycin ; Fingolimod ; Daclizumab ; Levetiracetam ; Sodium polystyrene sulfonate ; Radium-223 dichloride 590 Known risksAmoxicillin ; Moxifloxacin ; Palivizumab ; Cladribine ; Clozapine ; Buprenorphine, methadone 591 Review outcomesFactor VIII medicines592 Reviews startedHydroxyethyl starch;Ulipristal ;Febuxostat;Flupirtine-containing products.
573 WHO Drug Information Vol. 31, No. 4, 2017 Contents Safety of medicines 575 Priming resource-limited countries for pharmacovigilance Naming of medicines 581 Survey about International Nonproprietary Names (INN) Safety news
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: